Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


Articles published in Neurochem Res

Retrieve available abstracts of 54 articles:
HTML format



Single Articles


    July 2021
  1. PEREZ-BARRON G, Montes S, Aguirre-Vidal Y, Santiago M, et al
    Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP(+) Model of Parkinson's Disease.
    Neurochem Res. 2021 Jul 14. pii: 10.1007/s11064-021-03379.
    PubMed     Abstract available


    June 2021
  2. LIU X, Wang C, Liu W, Song S, et al
    Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.
    Neurochem Res. 2021 Jun 7. pii: 10.1007/s11064-021-03363.
    PubMed     Abstract available


    April 2021
  3. WANG X, Liu Z, Wang F
    MicroRNA-93 Blocks Signal Transducers and Activator of Transcription 3 to Reduce Neuronal Damage in Parkinson's Disease.
    Neurochem Res. 2021 Apr 26. pii: 10.1007/s11064-021-03333.
    PubMed     Abstract available


  4. RATHORE AS, Birla H, Singh SS, Zahra W, et al
    Epigenetic Modulation in Parkinson's Disease and Potential Treatment Therapies.
    Neurochem Res. 2021 Apr 26. pii: 10.1007/s11064-021-03334.
    PubMed     Abstract available


    March 2021
  5. LIU X, Liu S, Tang Y, Pu Z, et al
    Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Diseas
    Neurochem Res. 2021 Mar 15. pii: 10.1007/s11064-021-03293.
    PubMed     Abstract available


  6. ZENG X, An H, Yu F, Wang K, et al
    Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
    Neurochem Res. 2021 Mar 1. pii: 10.1007/s11064-021-03262.
    PubMed     Abstract available


    February 2021
  7. XIN C, Liu J
    Long Non-coding RNAs in Parkinson's Disease.
    Neurochem Res. 2021 Feb 5. pii: 10.1007/s11064-021-03230.
    PubMed     Abstract available


    January 2021
  8. RAJPUT C, Sarkar A, Sachan N, Rawat N, et al
    Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
    Neurochem Res. 2021 Jan 5. pii: 10.1007/s11064-020-03187.
    PubMed     Abstract available


    November 2020
  9. AVCI B, Gunaydin C, Guvenc T, Yavuz CK, et al
    Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.
    Neurochem Res. 2020 Nov 28. pii: 10.1007/s11064-020-03186.
    PubMed     Abstract available


  10. LIU T, Zhang Y, Liu W, Zhao J, et al
    LncRNA NEAT1 Regulates the Development of Parkinson's Disease by Targeting AXIN1 Via Sponging miR-212-3p.
    Neurochem Res. 2020 Nov 26. pii: 10.1007/s11064-020-03157.
    PubMed     Abstract available


  11. DONG Y, Xiong J, Ji L, Xue X, et al
    MiR-421 Aggravates Neurotoxicity and Promotes Cell Death in Parkinson's Disease Models by Directly Targeting MEF2D.
    Neurochem Res. 2020 Nov 12. pii: 10.1007/s11064-020-03166.
    PubMed     Abstract available


    September 2020
  12. PARAMBI DGT, Saleem U, Shah MA, Anwar F, et al
    Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson's Disease.
    Neurochem Res. 2020 Sep 16. pii: 10.1007/s11064-020-03130.
    PubMed     Abstract available


    July 2020
  13. LI W, Goshima Y, Ohshima T
    Loss of Collapsin Response Mediator Protein 4 Attenuates 6-Hydroxydopamine-Induced Impairments in a Mouse Model of Parkinson's Disease.
    Neurochem Res. 2020 Jul 9. pii: 10.1007/s11064-020-03086.
    PubMed     Abstract available


    June 2020
  14. ZHUANG W, Cai M, Li W, Chen C, et al
    Polyphenols from Toona sinensiss Seeds Alleviate Neuroinflammation Induced by 6-Hydroxydopamine Through Suppressing p38 MAPK Signaling Pathway in a Rat Model of Parkinson's Disease.
    Neurochem Res. 2020 Jun 17. pii: 10.1007/s11064-020-03067.
    PubMed     Abstract available


  15. QIAO CM, Sun MF, Jia XB, Li Y, et al
    Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model.
    Neurochem Res. 2020 Jun 16. pii: 10.1007/s11064-020-03074.
    PubMed     Abstract available


    May 2020
  16. SINGH A, Tripathi P, Yadawa AK, Singh S, et al
    Promising Polyphenols in Parkinson's Disease Therapeutics.
    Neurochem Res. 2020 May 27. pii: 10.1007/s11064-020-03058.
    PubMed     Abstract available


    April 2020
  17. ZHANG Y, Xia Q, Lin J
    LncRNA H19 Attenuates Apoptosis in MPTP-Induced Parkinson's Disease Through Regulating miR-585-3p/PIK3R3.
    Neurochem Res. 2020 Apr 30. pii: 10.1007/s11064-020-03035.
    PubMed     Abstract available


    January 2020
  18. LIN F, Wu D, Lin C, Cai H, et al
    Pedunculopontine Nucleus Deep Brain Stimulation Improves Gait Disorder in Parkinson's Disease: A Systematic Review and Meta-analysis.
    Neurochem Res. 2020 Jan 16. pii: 10.1007/s11064-020-02962.
    PubMed     Abstract available


    November 2019
  19. MAZURSKYY A, Howitt J
    Initiation and Transmission of alpha-Synuclein Pathology in Parkinson's Disease.
    Neurochem Res. 2019 Nov 11. pii: 10.1007/s11064-019-02896.
    PubMed     Abstract available


    October 2019
  20. ESSA MM, Subash S, Dhanalakshmi C, Manivasagam T, et al
    Correction to: Dietary Supplementation of Walnut Partially Reverses 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Neurodegeneration in a Mouse Model of Parkinson's Disease.
    Neurochem Res. 2019 Oct 18. pii: 10.1007/s11064-019-02887.
    PubMed     Abstract available


    September 2019
  21. ZHANG Q, Lei YH, Zhou JP, Hou YY, et al
    Role of PGC-1alpha in Mitochondrial Quality Control in Neurodegenerative Diseases.
    Neurochem Res. 2019;44:2031-2043.
    PubMed     Abstract available


    August 2019
  22. BETHARIA S, Rondomicronn-Ortiz AN, Brown DA
    Disubstituted Dithiolethione ACDT Exerts Neuroprotective Effects Against 6-Hydroxydopamine-Induced Oxidative Stress in SH-SY5Y Cells.
    Neurochem Res. 2019;44:1878-1892.
    PubMed     Abstract available


    May 2019
  23. TOTH A, Antal Z, Bereczki D, Sperlagh B, et al
    Purinergic Signalling in Parkinson's Disease: A Multi-target System to Combat Neurodegeneration.
    Neurochem Res. 2019 May 4. pii: 10.1007/s11064-019-02798.
    PubMed     Abstract available


    April 2019
  24. ZYGOGIANNI O, Antoniou N, Kalomoiri M, Kouroupi G, et al
    In Vivo Phenotyping of Familial Parkinson's Disease with Human Induced Pluripotent Stem Cells: A Proof-of-Concept Study.
    Neurochem Res. 2019 Apr 15. pii: 10.1007/s11064-019-02781.
    PubMed     Abstract available


    February 2019
  25. NING B, Zhang Q, Wang N, Deng M, et al
    beta-Asarone Regulates ER Stress and Autophagy Via Inhibition of the PERK/CHOP/Bcl-2/Beclin-1 Pathway in 6-OHDA-Induced Parkinsonian Rats.
    Neurochem Res. 2019 Feb 22. pii: 10.1007/s11064-019-02757.
    PubMed     Abstract available


  26. ZHENG X, Huang Z, Zhu Y, Liu B, et al
    Increase in Glutamatergic Terminals in the Striatum Following Dopamine Depletion in a Rat Model of Parkinson's Disease.
    Neurochem Res. 2019 Feb 4. pii: 10.1007/s11064-019-02739.
    PubMed     Abstract available


    January 2019
  27. GUREEV AP, Popov VN
    Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases.
    Neurochem Res. 2019 Jan 7. pii: 10.1007/s11064-018-02711.
    PubMed     Abstract available


  28. PROROK T, Jana M, Patel D, Pahan K, et al
    Cinnamic Acid Protects the Nigrostriatum in a Mouse Model of Parkinson's Disease via Peroxisome Proliferator-Activated Receptoralpha.
    Neurochem Res. 2019 Jan 5. pii: 10.1007/s11064-018-02705.
    PubMed     Abstract available


    October 2018
  29. JIANG Y, Cao Z, Ma H, Wang G, et al
    Auricular Vagus Nerve Stimulation Exerts Antiinflammatory Effects and Immune Regulatory Function in a 6-OHDA Model of Parkinson's Disease.
    Neurochem Res. 2018 Oct 11. pii: 10.1007/s11064-018-2639.
    PubMed     Abstract available


    September 2018
  30. HORST CH, Schlemmer F, de Aguiar Montenegro N, Domingues ACM, et al
    Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats.
    Neurochem Res. 2018 Sep 28. pii: 10.1007/s11064-018-2638.
    PubMed     Abstract available


    August 2018
  31. LAI F, Jiang R, Xie W, Liu X, et al
    Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Neurochem Res. 2018 Aug 31. pii: 10.1007/s11064-018-2620.
    PubMed     Abstract available


  32. REKHA KR, Inmozhi Sivakamasundari R
    Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
    Neurochem Res. 2018 Aug 23. pii: 10.1007/s11064-018-2617.
    PubMed     Abstract available


    April 2018
  33. SARUKHANI MR, Haghdoost-Yazdi H, Khandan-Chelarci G
    Changes in the Serum Urate Level Can Predict the Development of Parkinsonism in the 6-Hydroxydopamine Animal Model.
    Neurochem Res. 2018 Apr 3. pii: 10.1007/s11064-018-2522.
    PubMed     Abstract available


    March 2018
  34. WANG X, Pang L, Zhang Y, Xu J, et al
    Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson's Disease.
    Neurochem Res. 2018 Mar 28. pii: 10.1007/s11064-018-2499.
    PubMed     Abstract available


  35. NEWMAN-TANCREDI A, Varney MA, McCreary AC
    Effects of the Serotonin 5-HT1A Receptor Biased Agonists, F13714 and F15599, on Striatal Neurotransmitter Levels Following L-DOPA Administration in Hemi-Parkinsonian Rats.
    Neurochem Res. 2018 Mar 23. pii: 10.1007/s11064-018-2514.
    PubMed     Abstract available


    September 2017
  36. UR RASHEED MS, Mishra AK, Singh MP
    Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.
    Neurochem Res. 2017 Sep 4. doi: 10.1007/s11064-017-2384.
    PubMed     Abstract available


    August 2017
  37. ZHAO Z, Wang J, Wang L, Yao X, et al
    Capsaicin Protects Against Oxidative Insults and Alleviates Behavioral Deficits in Rats with 6-OHDA-Induced Parkinson's Disease via Activation of TRPV1.
    Neurochem Res. 2017 Aug 31. doi: 10.1007/s11064-017-2388.
    PubMed     Abstract available


  38. LIMA FAV, Joventino IP, Joventino FP, de Almeida AC, et al
    Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects.
    Neurochem Res. 2017 Aug 31. doi: 10.1007/s11064-017-2379.
    PubMed     Abstract available


    June 2017
  39. NIU J, Xiong J, Hu D, Zeng F, et al
    2',3'-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease.
    Neurochem Res. 2017 Jun 19. doi: 10.1007/s11064-017-2330.
    PubMed     Abstract available


    May 2017
  40. YOSHII Y, Inoue T, Uemura Y, Iwasaki Y, et al
    Complexity of Stomach-Brain Interaction Induced by Molecular Hydrogen in Parkinson's Disease Model Mice.
    Neurochem Res. 2017 May 2. doi: 10.1007/s11064-017-2281.
    PubMed     Abstract available


    February 2017
  41. MAO Z, Liu C, Ji S, Yang Q, et al
    The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson's Disease in Rats.
    Neurochem Res. 2017 Feb 28. doi: 10.1007/s11064-017-2185.
    PubMed     Abstract available


  42. YUE P, Gao L, Wang X, Ding X, et al
    Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3beta Pathway.
    Neurochem Res. 2017 Feb 28. doi: 10.1007/s11064-017-2184.
    PubMed     Abstract available


  43. LOPEZ-FABUEL I, Resch-Beusher M, Carabias-Carrasco M, Almeida A, et al
    Mitochondrial Complex I Activity is Conditioned by Supercomplex I-III2-IV Assembly in Brain Cells: Relevance for Parkinson's Disease.
    Neurochem Res. 2017 Feb 14. doi: 10.1007/s11064-017-2191.
    PubMed     Abstract available


  44. NATARAJ J, Manivasagam T, Justin Thenmozhi A, Essa MM, et al
    Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson's disease: The Role of MAPK, PI3K-Akt-GSK3beta and mTOR Signalling
    Neurochem Res. 2017 Feb 8. doi: 10.1007/s11064-017-2183.
    PubMed     Abstract available


    January 2017
  45. WANG T, Wang L, Li C, Han B, et al
    Hydroxysafflor Yellow A Improves Motor Dysfunction in the Rotenone-Induced Mice Model of Parkinson's Disease.
    Neurochem Res. 2017 Jan 17. doi: 10.1007/s11064-017-2176.
    PubMed     Abstract available


    December 2016
  46. CHEN L, Cheng L, Wei X, Yuan Z, et al
    Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3beta Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.
    Neurochem Res. 2016 Dec 22. doi: 10.1007/s11064-016-2148.
    PubMed     Abstract available


  47. ZHANG J, Zhang Z, Xiang J, Cai M, et al
    Neuroprotective Effects of Echinacoside on Regulating the Stress-Active p38MAPK and NF-kappaB p52 Signals in the Mice Model of Parkinson's Disease.
    Neurochem Res. 2016.
    PubMed     Abstract available


  48. REN M, Han M, Wei X, Guo Y, et al
    FTY720 Attenuates 6-OHDA-Associated Dopaminergic Degeneration in Cellular and Mouse Parkinsonian Models.
    Neurochem Res. 2016.
    PubMed     Abstract available


  49. HAINING RL, Jones TM, Hernandez A
    Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.
    Neurochem Res. 2016;41:3356-3363.
    PubMed     Abstract available


    September 2016
  50. FARZANEHFAR P
    Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis.
    Neurochem Res. 2016.
    PubMed     Abstract available


  51. KWAKYE GF, McMinimy RA, Aschner M
    Disease-Toxicant Interactions in Parkinson's Disease Neuropathology.
    Neurochem Res. 2016.
    PubMed     Abstract available


  52. GOLDSTEIN DS, Jinsmaa Y, Sullivan P, Holmes C, et al
    3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
    Neurochem Res. 2016;41:2173-8.
    PubMed     Abstract available


    May 2016
  53. KIASALARI Z, Khalili M, Baluchnejadmojarad T, Roghani M, et al
    Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.
    Neurochem Res. 2016;41:1065-72.
    PubMed     Abstract available


    March 2016
  54. JARROTT B, Williams SJ
    Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation.
    Neurochem Res. 2016;41:523-33.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: